Paper23344265
B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.
Carpenter RO and 8 others. Clin Cancer Res, 2013. Cited by 564 papers, by iCite.
Cite this record
ConductScience Library. B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Papers, record 23344265. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23344265
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Cell Maturation Antigen | Major topic |
| Multiple Myeloma | Major topic |
| Receptors, Antigen, T-Cell | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cytotoxicity, Immunologic | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Immunohistochemistry | |
| Immunotherapy, Adoptive | |
| Interleukin Receptor Common gamma Subunit | |
| K562 Cells | |
| Mice | |
| Mice, Inbred NOD | |
| Mice, Knockout | |
| Mice, SCID | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| ZIA BC011439 | Intramural NIH HHS | United States | ZIABC011439 | PubMed and NIH | NIH RePORTER |
| ZIABC010957 | NIH | NIH RePORTER | |||
| ZICBC010934 | NIH | NIH RePORTER | |||
| ZICBC011029 | NIH | NIH RePORTER | |||
| ZICBC011087 | NIH | NIH RePORTER |
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02215967 | Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma | Background | ClinicalTrials.gov | |
| NCT03706547 | Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM | Background | ClinicalTrials.gov | |
| NCT05849610 | Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 23444214 | Zoom Zoom: racing CARs for multiple myeloma. | https://conductscience.org/library/papers/23444214 |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20631379 | Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells. | Blood | 2010 | https://conductscience.org/library/papers/20631379 | PubMed |
| 2 | 21658650 | Reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma: a concise review. | Clin Lymphoma Myeloma Leuk | 2011 | https://conductscience.org/library/papers/21658650 | PubMed |
| 3 | 21522124 | Treatment of multiple myeloma. | Nat Rev Clin Oncol | 2011 | https://conductscience.org/library/papers/21522124 | PubMed |
| 4 | 16322746 | Supernatural T cells: genetic modification of T cells for cancer therapy. | Nat Rev Immunol | 2005 | https://conductscience.org/library/papers/16322746 | PubMed |
| 5 | 16818641 | Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. | Cancer Res | 2006 | https://conductscience.org/library/papers/16818641 | PubMed |
| 6 | 1396583 | A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma. | EMBO J | 1992 | https://conductscience.org/library/papers/1396583 | PubMed |
| 7 | 11509691 | An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. | Science | 2001 | https://conductscience.org/library/papers/11509691 | PubMed |
| 8 | 781899 | Distribution of plasma cells and other cells containing immunoglobulin in the respiratory tract of normal man and class of immunoglobulin contained therein. | Thorax | 1976 | https://conductscience.org/library/papers/781899 | PubMed |
| 9 | 22127019 | Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor. | Mol Ther | 2012 | https://conductscience.org/library/papers/22127019 | PubMed |
| 10 | 21852787 | Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma. | Leukemia | 2012 | https://conductscience.org/library/papers/21852787 | PubMed |
| 11 | 22804669 | Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival. | Br J Haematol | 2012 | https://conductscience.org/library/papers/22804669 | PubMed |
| 12 | 19561539 | Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor. | J Immunother | 2009 | https://conductscience.org/library/papers/19561539 | PubMed |
| 13 | 21830940 | Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21830940 | PubMed |
| 14 | 21777223 | Monoclonal antibodies in the treatment of multiple myeloma. | Br J Haematol | 2011 | https://conductscience.org/library/papers/21777223 | PubMed |
| 15 | 21157437 | T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. | Mol Ther | 2011 | https://conductscience.org/library/papers/21157437 | PubMed |
| 16 | 17968879 | Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL. | Arthritis Rheum | 2007 | https://conductscience.org/library/papers/17968879 | PubMed |
| 17 | 12579196 | Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. | Nat Med | 2003 | https://conductscience.org/library/papers/12579196 | PubMed |
| 18 | 20428207 | Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety. | Leukemia | 2010 | https://conductscience.org/library/papers/20428207 | PubMed |
| 19 | 15692072 | Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor. | Blood | 2005 | https://conductscience.org/library/papers/15692072 | PubMed |
| 20 | 21849486 | Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. | Blood | 2011 | https://conductscience.org/library/papers/21849486 | PubMed |
Cited by408
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 564 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42980050 | Bispecific antibodies targeting B-cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions. | Cancer | 2026 | https://conductscience.org/library/papers/42980050 | PubMed |
| 42974396 | Identification of B-cell maturation antigen (BCMA)-targeting peptides and selective drug delivery to multiple myeloma using peptide-targeted DM1 prodrug-loaded nanoparticles. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/42974396 | PubMed |
| 42806527 | Clinical Impact of CTLA4 and LAG3 Single-Nucleotide Polymorphisms in Multiple Myeloma Patients Treated With BCMA CAR T-Cell Therapy. | Hematol Oncol | 2026 | https://conductscience.org/library/papers/42806527 | PubMed |
| 42755123 | BAFF and APRIL Receptors in B Cell Immunity and Autoimmunity. | Immunol Rev | 2026 | https://conductscience.org/library/papers/42755123 | PubMed |
| 42733076 | Enhancing iNKT cell immunotherapy through the integration of optimized CAR endodomains and iNKT engagers. | Nat Commun | 2026 | https://conductscience.org/library/papers/42733076 | PubMed |
| 42708148 | Radiocopper in BCMA-targeted immunotheranostics of myeloma. | Theranostics | 2026 | https://conductscience.org/library/papers/42708148 | PubMed |
| 42686747 | T cell senescence and exhaustion: molecular mechanisms and immune rejuvenation for cancer immunotherapy. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42686747 | PubMed |
| 42681422 | Modeling the Application of Chimeric Antigen Receptor T Cell Therapy to Eliminate Alloantibodies in Mice. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42681422 | PubMed |
| 42605790 | Metabolic activation using fructose-1,6-bisphosphate microparticles of non-virally LNP-generated CAR-macrophages induces anti-tumor immune responses. | J Mater Chem B | 2026 | https://conductscience.org/library/papers/42605790 | PubMed |
| 42405950 | Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation. | J Exp Med | 2026 | https://conductscience.org/library/papers/42405950 | PubMed |
| 42315760 | Current status and challenges of TCR-T cell therapy for AML/MDS. | Int J Hematol | 2026 | https://conductscience.org/library/papers/42315760 | PubMed |
| 42157940 | Immunologic Combinations in Multiple Myeloma: Synergistic Stimulation with T cells and NK cells. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42157940 | PubMed |
| 42104450 | Nanotechnology-enhanced CAR-T therapy strategies in cancer, aging, and autoimmune diseases. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42104450 | PubMed |
| 41976339 | Extracellular Vesicle IL5RA and BCMA in Serum Enable Non-Invasive Risk Stratification of Multiple Myeloma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976339 | PubMed |
| 41942445 | Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response. | Nat Commun | 2026 | https://conductscience.org/library/papers/41942445 | PubMed |
| 41892338 | Empowerment of CAR-T Cells by IL-7 and IL-15 Boosts Their Efficacy Against HER2-Positive Tumors with Enhanced Expansion and Persistence. | Cells | 2026 | https://conductscience.org/library/papers/41892338 | PubMed |
| 41871876 | Limited expression of B-cell maturation antigen in acute myeloid leukemia. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41871876 | PubMed |
| 41861264 | Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma. | JCO Clin Cancer Inform | 2026 | https://conductscience.org/library/papers/41861264 | PubMed |
| 41749939 | Soluble B-Cell Maturation Antigen as a Prognostic Marker for Progression-Free Survival in Multiple Myeloma Treated with BCMA-Directed Therapies: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41749939 | PubMed |
| 41749925 | The Role of Rarely Studied Chemokines in Tumor Progression in Multiple Myeloma (MM). | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41749925 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23344265
GET https://conductscience.org/api/papers/v1/23344265/references?page=2